These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease? Jácome AA; Lima EM; Kazzi AI; Chaves GF; Mendonça DC; Maciel MM; Santos JS Rev Soc Bras Med Trop; 2016 Apr; 49(2):150-7. PubMed ID: 27192582 [TBL] [Abstract][Full Text] [Related]
23. Cluster classification of a Brazilian gastric cancer cohort reveals remarkable populational differences in normal p53 rate. Queiroz FR; Braga LDC; Melo CPS; Gomes MS; Amaral LRD; Salles PGO Einstein (Sao Paulo); 2024; 22():eAO0508. PubMed ID: 39356938 [TBL] [Abstract][Full Text] [Related]
24. Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study. Yoon JY; Sy K; Brezden-Masley C; Streutker CJ PLoS One; 2019; 14(12):e0224812. PubMed ID: 31790410 [TBL] [Abstract][Full Text] [Related]
25. Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas. Razzak M Nat Rev Clin Oncol; 2014 Sep; 11(9):499. PubMed ID: 25113841 [No Abstract] [Full Text] [Related]
26. Molecular classification of gastric cancer: a new paradigm. Shah MA; Khanin R; Tang L; Janjigian YY; Klimstra DS; Gerdes H; Kelsen DP Clin Cancer Res; 2011 May; 17(9):2693-701. PubMed ID: 21430069 [TBL] [Abstract][Full Text] [Related]
28. Comparison and applicability of molecular classifications for gastric cancer. Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213 [TBL] [Abstract][Full Text] [Related]
29. TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics. Zhang W Chin J Cancer; 2014 Oct; 33(10):469-70. PubMed ID: 25223913 [TBL] [Abstract][Full Text] [Related]
30. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue. Heo YJ; Park C; Yu D; Lee J; Kim KM Sci Rep; 2019 Jul; 9(1):9675. PubMed ID: 31273278 [TBL] [Abstract][Full Text] [Related]
31. DEMoS: a deep learning-based ensemble approach for predicting the molecular subtypes of gastric adenocarcinomas from histopathological images. Wang Y; Hu C; Kwok T; Bain CA; Xue X; Gasser RB; Webb GI; Boussioutas A; Shen X; Daly RJ; Song J Bioinformatics; 2022 Sep; 38(17):4206-4213. PubMed ID: 35801909 [TBL] [Abstract][Full Text] [Related]
32. Molecular classification of gastric cancer. Chia NY; Tan P Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606 [TBL] [Abstract][Full Text] [Related]
34. Implementing an integrated molecular classification for gastric cancer from endoscopic biopsies using on-slide tests. Costache S; Baltan A; Diaz McLynn S; Pegoraro M; de Havilland R; Porter M; Lerga A; Thomas T; Chefani AE; Wedden S; Billingham K; D'Arrigo C Rom J Morphol Embryol; 2024; 65(2):257-265. PubMed ID: 39020540 [TBL] [Abstract][Full Text] [Related]
36. THE MOLECULAR CANCER SUBTYPES VERSUS THE INDUSTRY ARSENAL. WHICH ONE DRIVES GASTRIC CANCER TREATMENT? Assumpção PP; Kassab P Arq Bras Cir Dig; 2024; 37():e1811. PubMed ID: 38958347 [TBL] [Abstract][Full Text] [Related]
37. Stromal-Based Signatures for the Classification of Gastric Cancer. Uhlik MT; Liu J; Falcon BL; Iyer S; Stewart J; Celikkaya H; O'Mahony M; Sevinsky C; Lowes C; Douglass L; Jeffries C; Bodenmiller D; Chintharlapalli S; Fischl A; Gerald D; Xue Q; Lee JY; Santamaria-Pang A; Al-Kofahi Y; Sui Y; Desai K; Doman T; Aggarwal A; Carter JH; Pytowski B; Jaminet SC; Ginty F; Nasir A; Nagy JA; Dvorak HF; Benjamin LE Cancer Res; 2016 May; 76(9):2573-86. PubMed ID: 27197264 [TBL] [Abstract][Full Text] [Related]
38. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis. Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951 [TBL] [Abstract][Full Text] [Related]
40. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]